These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10686641)

  • 1. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT.
    Belin C; Moroni C; Caillat-Vigneron N; Debray M; Baudin M; Dumas JL; Moretti JL; Delaporte P; Guillevin L
    Ann Med Interne (Paris); 1999 Dec; 150(8):598-604. PubMed ID: 10686641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome.
    Kao CH; Ho YJ; Lan JL; ChangLai SP; Chieng PU
    J Nucl Med; 1998 Aug; 39(8):1354-6. PubMed ID: 9708505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study.
    Le Guern V; Belin C; Henegar C; Moroni C; Maillet D; Lacau C; Dumas JL; Vigneron N; Guillevin L
    Ann Rheum Dis; 2010 Jan; 69(1):132-7. PubMed ID: 19158115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome.
    Kao CH; Lan JL; ChangLai SP; Chieng PU
    J Nucl Med; 1998 May; 39(5):773-7. PubMed ID: 9591573
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Frantellizzi V; Morreale M; Pontico M; Francia A; Drudi FM; Farcomeni A; Liberatore M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):211-217. PubMed ID: 29605630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-HMPAO SPECT and MRI of brain in patients with neuro-Behçet's syndrome.
    Kao CH; Lan JL; ChangLai SP; Chieng PU
    J Nucl Med; 1998 Oct; 39(10):1707-10. PubMed ID: 9776273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients.
    Govoni M; Bajocchi G; Rizzo N; Tola MR; Caniatti L; Tugnoli V; Colamussi P; Trotta F
    Clin Rheumatol; 1999; 18(4):299-303. PubMed ID: 10468169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-HmPAO single photon emission tomography, magnetic resonance proton spectroscopy and neuropsychological testing in evaluation of carbon monoxide neurotoxicity.
    Pach D; Urbanik A; Szczepańska L; Hubalewska A; Huszno B; Groszek B; Jenner B
    Przegl Lek; 2005; 62(6):441-5. PubMed ID: 16225091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cerebral blood flow-SPECT in chronic alcoholism: relation to neuropsychological testing.
    Nicolás JM; Catafau AM; Estruch R; Lomeña FJ; Salamero M; Herranz R; Monforte R; Cardenal C; Urbano-Marquez A
    J Nucl Med; 1993 Sep; 34(9):1452-9. PubMed ID: 8355063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance.
    Ichise M; Chung DG; Wang P; Wortzman G; Gray BG; Franks W
    J Nucl Med; 1994 Feb; 35(2):217-26. PubMed ID: 8294988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
    Lin WY; Wang SJ; Yen TC; Lan JL
    J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Sjogren's syndrome with central nervous system involvement.
    Alhomoud IA; Bohlega SA; Alkawi MZ; Alsemari AM; Omer SM; Alsenani FM
    Saudi Med J; 2009 Aug; 30(8):1067-72. PubMed ID: 19668890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-HMPAO brain SPECT in Behçet's disease.
    García-Burillo A; Castell J; Fraile M; Jacas C; Vilardell M; Ortega D; Bosch JA
    J Nucl Med; 1998 Jun; 39(6):950-4. PubMed ID: 9627324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren syndrome.
    Mataró M; Escudero D; Ariza M; Sánchez-Ojanguren J; Latorre P; Junqué C; Mercader JM
    J Neurol; 2003 Sep; 250(9):1070-6. PubMed ID: 14504968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system (CNS) manifestations of primary Sjögren's syndrome: an overview.
    Alexander EL
    Scand J Rheumatol Suppl; 1986; 61():161-5. PubMed ID: 3473627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.
    Govoni M; Padovan M; Rizzo N; Trotta F
    CNS Drugs; 2001; 15(8):597-607. PubMed ID: 11524032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET.
    Lass P; Krajka-Lauer J; Homziuk M; Iwaszkiewicz-Bilikiewicz B; Koseda M; Hebanowski M; Lyczak P
    Nucl Med Commun; 2000 Jan; 21(1):31-5. PubMed ID: 10717899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Sjögren's syndrome with dementia in a memory clinic.
    Yoshikawa K; Hatate J; Toratani N; Sugiura S; Shimizu Y; Takahash T; Ito T; Fukunaga R
    J Neurol Sci; 2012 Nov; 322(1-2):217-21. PubMed ID: 22901967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of central nervous system involvement associated with primary Sjögren's syndrome.
    Ozgocmen S; Gur A
    Curr Pharm Des; 2008; 14(13):1270-3. PubMed ID: 18537651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of brain SPECT with HMPAO-99mTc and psychological tests for diagnosis of neurological involvement in Behçet's disease].
    García Hernández FJ; Ocaña Medina C; Mateos Romero L; Sánchez Román J; García Solís D; Franco-Baux JR; Mora Roche J; Mora Merchán J
    Med Clin (Barc); 2002 Oct; 119(12):447-50. PubMed ID: 12385651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.